Altimmune Inc (NYSE:ALT) Ends Up After Bouncy 113.24% Swing

Altimmune Inc (NYSE:ALT)

September 20th, 2018

With markets going up Altimmune Inc closed Thursday up 59.36%, a $9.77 increase to close on $26.23. Altimmune Inc swung 113.24% between low and high. The stock continues to trade well at 10,392% of its 52 week low of $0.25. In addition to finishing higher, trading volumes were solid at 2,274% of normal which can indicate investors see opportunities.

ALT outperformed the rest of the Healthcare sector which went up 0.93% today.

Market Sectors

The market sectors were mixed Thursday with a majority of the sectors trending up. Information Technology saw the biggest increase of the day (1.17%), while Energy saw the biggest drop (0.06%). Consumer Discretionary has seen the biggest year-to-date gain at 18%. The biggest loss this year has been the Telecommunication Services sector falling 5.70%.

Consumer Staples saw the biggest turnaround from its 5-day performance of -0.82%, as it went up 1.16%. Energy saw a turn around from its 5-day performance of 1.82% trading down 0.06%.

Sector Breakdown

  • Information Technology went up with a 1.17% change.
  • Consumer Staples went up with a 1.16% change.
  • Materials went up with a 1.05% change.
  • Healthcare went up with a 0.93% change.
  • Financials went up with a 0.80% change.
  • Real Estate went up with a 0.76% change.
  • Consumer Discretionary went up with a 0.66% change.
  • Telecommunication Services went up with a 0.45% change.
  • Utilities went up with a 0.12% change.
  • Industrials went up with a 0.11% change.
  • Energy went down with a -0.06% change.

Altimmune Inc Info

As of May 4, 2017, PharmAthene, Inc. was acquired by Altimmune, Inc. in a reverse merger transaction. PharmAthene, Inc., a biodefense company, develops and commercializes medical countermeasures against biological and chemical threats in the United States. The company focuses on developing lyophilized anthrax vaccine based on its proprietary technology platform. It serves National Institute of Allergy and Infectious Diseases, and the Biomedical Advanced Research and Development Authority. PharmAthene, Inc. is headquartered in Annapolis, Maryland.

All amounts in USD unless otherwise indicated

ALT daily update
ALT daily update

Media Gazelle Inc (MG), a Nevada Corporation, owns and operates the online brand US Tribune News. MG does not offer financial advise, and is not a registered broker/dealer/analyst/adviser, holds no investment licenses, and may not sell, offer to sell or offer to buy any security. MG’s market updates, news are not a solicitation or recommendation to buy, sell or hold securities. MG shall not be held liable for any investment losses you may incur by using the information provided, this includes you trading the stocks mentioned on our sites. We recommend you talk to a financial adviser before trading any securities or taking any action based upon information on this site. MG does not guarantee the accuracy of the article.